Thursday, 25 February 2021

Successful AAALAC accreditation for Envigo facilities in Hyderabad

01 June 2017 | News

This is the first accreditation of Envigo sites in 2017 and the sixth in total since the launch of the new company in 2015

Envigo has announced that its Research Models and Services (RMS) facility in Hyderabad, India has been granted full accreditation by the Association for Assessment and Accreditation of Laboratory Animal Care (AAALAC) International Council.

This is the first accreditation of Envigo sites in 2017 and the sixth in total since the launch of the new company in 2015. The award demonstrates ongoing progress towards Envigo’s goal to have all of its European and Asian research models sites accredited by AAALAC. All of Envigo’s US sites are already AAALAC accredited.

AAALAC commended Envigo’s Indian facility for providing and maintaining a high quality program of laboratory animal care and use, well qualified employees, dedicated engineering and maintenance teams, and highly engaged IACUC (IAEC) members. The cleanliness and maintenance of the facilities were also praised by inspectors.

John Handley, President of EMEA Operations commented: “I am delighted that our team and facility in India have been recognized by the industry-leading AAALAC accreditation. The quality of care and expertise at Hyderabad facility were highlighted by the auditors – a testament to the professionalism of our employees who work in partnership with customers around the world to advance research that makes the world a safer and healthier place.”

“As non-clinical development continues to proliferate on a global basis, it is important for our local and Western customers to have access to high quality, proven research models to conduct their research in Asia. Having gained AAALAC accreditation, the new Indian facility will help serve that industry need.” , he added



× Your session has been expired. Please click here to Sign-in or Sign-up
   New User? Create Account

Survey Box

Should we be cautious of viewing COVID-19 vaccine as silver bullet?

× Please select an option to participate in the poll.
Processing...   View poll results   More polls

× You have successfully cast your vote.
{{ optionDetail.option }}{{ optionDetail.percentage }}%
{{ optionDetail.percentage }}% Complete
More polls